Anna Eramo
Equibles does not estimate personal net worth.
About Anna Eramo
Lb Pharmaceuticals Inc reported in an 8-K filed June 10, 2026 that Anna Eramo resigned as Chief Medical Officer, effective June 15, 2026. The proxy statement of Lb Pharmaceuticals Inc reports total compensation of $2,376,939 for Anna Eramo in fiscal 2025, including a base salary of $414,063. Disclosed compensation is on record for 2 fiscal years.
“On June 8, 2026, she resigned from her position as Chief Medical Officer of the Company effective June 15, 2026 (the "Separation Date").”
Affiliation history
-
Lb Pharmaceuticals Inc (LBRX)
Proxy statement
Start not stated–2026-06-15
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Lb Pharmaceuticals Inc (LBRX) | Chief Medical Officer | $414,063 | $2,376,939 |
| 2024 | Lb Pharmaceuticals Inc (LBRX) | Chief Medical Officer | $375,000 | $891,050 |